Modernizing the Two-Tier Diagnostic Framework
The Problem: Outdated Two-Tier Testing in a Complex Clinical Landscape
Standard Lyme and co-infection diagnostics have not evolved at the pace of emerging research. Conventional antibody-based testing can lack sufficient sensitivity and specificity, particularly in early infection or in cases involving multiple pathogens.
As a result, clinicians are often left managing complex, chronic presentations without definitive laboratory confirmation. This diagnostic uncertainty can delay targeted treatment decisions, complicate patient management, and increase the clinical burden in already time-constrained practices.
It is time to re-evaluate and modernize the traditional two-tier diagnostic model.
Why Attend
Expert Insight
Hear directly from Dr. Cory Tichauer, a leading Lyme-literate naturopathic doctor, on how diagnostic strategy impacts real-world patient outcomes and complex case management.
Validated Science
Review data with ArminLab developers and scientists on advanced microarray technology demonstrating up to 95–98% sensitivity and >96% specificity for Borrelia detection, with expanded pathogen coverage.
Comprehensive Testing
Explore how multi-pathogen antibody panels can enhance diagnostic clarity and complement clinical evaluation in patients with suspected tick-borne illness.
Live Q&A
Engage in a live clinical discussion and ask questions about implementation, interpretation, and real-world application.
Implementation Insights
Learn how modernized testing tools can open testing to home-bound, young and elderly patients, and support more confident clinical decision-making.
More About Your Host: Dr. Cory Tichauer
Dr. Cory Tichauer, ND, LLND
Lyme-Literate Naturopathic Doctor • Board Member of ILADS • Founding Partner of Jivora Health
With over two decades in integrative and infectious disease medicine, Dr. Tichauer has helped thousands uncover the underlying causes of chronic illness. Through Jivora Health, he brings together validated diagnostic science, global laboratory partnerships, and a clinician-guided framework to make advanced tick-borne testing accessible and actionable.
Limited Capacity Event
Registration will close once maximum attendance is reached.
Due to the specialized nature of this clinical session, enrollment is limited.
Monday, February 23 at 9:00 AM Pacific Time | 10:00 AM Mountain Time | 11:00 AM Central Time | 12:00 PM Eastern Time
Attend Live or Sign Up for the Replay
Register Here to Guarantee Access to the Replay
Key Clinical Takeaways
Diagnostic & Implementation Insights
- Traditional ELISA and Western Blot testing may fail to detect clinically relevant immune markers, particularly in early or complex presentations.
- Borrelia’s pleomorphic behavior and antigenic variability can limit the reliability of single-antigen assays.
- Broader immune profiling improves diagnostic sensitivity and provides greater clarity in patients with multifactorial or persistent symptom patterns.
- Jivora’s practitioner-focused testing panels, powered by ArminLabs, utilize validated microarray technology to support comprehensive pathogen assessment.
Who This Webinar is For
Healthcare Practitioners
Clinicians managing patients with suspected Lyme disease, co-infections, or complex chronic symptom presentations.
Integrative & Functional Medicine Providers
Providers seeking expanded, multi-pathogen immune profiling to complement clinical assessment and improve diagnostic clarity.
Infectious Disease & Tick-Borne Specialists
Practitioners interested in advancing beyond traditional two-tier testing models and incorporating next-generation microarray diagnostics.
Medical Professionals Focused on Complex Cases
Healthcare providers treating persistent, atypical, or treatment-resistant presentations who require higher specificity and broader immune marker insight.
Live Monday, February 23rd • 9:00 AM Pacific Time | 10:00 AM Mountain Time | 11:00 AM Central Time | 12:00 PM Eastern Time
Advance Beyond the Limitations of Traditional Testing
Accurate detection informs better clinical decisions.
Explore what legacy assays may overlook, and what is now achievable through validated, next-generation immune profiling.
Compliance & Regulatory Disclaimer
The laboratory tests offered through Jivora Health are performed by Armin Labs, a CAP- and CLIA-certified laboratory that meets all applicable quality and regulatory standards for high-complexity testing. These laboratory-developed tests (LDTs) were designed and validated by Armin Labs and have not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA does not currently require clearance or approval for LDTs that are performed in certified laboratories.
All test results are provided for informational and educational purposes only. They are not intended to diagnose, treat, cure, or prevent any disease and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions you may have regarding your medical condition or before starting any healthcare regimen.
Any review sessions or discussions with Jivora Health practitioners are educational in nature and intended to help you better understand your lab report. These sessions do not constitute medical care or replace the advice of your licensed healthcare provider.
© 2025-2026 Jivora Health | All rights reserved
